{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T07:02:07Z","timestamp":1648623727534},"reference-count":35,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.3892\/ijo.2014.2361","type":"journal-article","created":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T13:37:51Z","timestamp":1395927471000},"page":"2016-2024","source":"Crossref","is-referenced-by-count":2,"title":["Antibody ligation of CM1 on cisplatin-exposed HeLa cells induces apoptosis through reactive oxygen species-dependent Fas ligand expression"],"prefix":"10.3892","volume":"44","author":[{"given":"GA BIN","family":"PARK","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DAEJIN","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HOI SOO","family":"YOON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YEONG-SEOK","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"HYUN-KYUNG","family":"LEE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"KI TAE","family":"KIM","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DAE HOON","family":"JEONG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DAE YOUNG","family":"HUR","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,3,27]]},"reference":[{"key":"key20180107182703_b1-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key20180107182703_b2-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc798","article-title":"Papillomaviruses and cancer: from basic studies to clinical application","volume":"2","author":"ZurHausen","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"key20180107182703_b3-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1470-2045(09)70335-3","article-title":"Cancer sur vival in Africa, Asia, and Central America: a population-based study","volume":"11","author":"Sankaranarayanan","year":"2010","journal-title":"Lancet Oncol"},{"key":"key20180107182703_b4-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1097\/CCO.0b013e32833af426","article-title":"Locally advanced cervical cancer: what is the standard of care?","volume":"22","author":"Al-Mansour","year":"2010","journal-title":"Curr Opin Oncol"},{"key":"key20180107182703_b5-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1097\/00001622-199012000-00014","article-title":"Alkylating and platinum-based agents","volume":"2","author":"Eastman","year":"1990","journal-title":"Curr Opin Oncol"},{"key":"key20180107182703_b6-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1368-7646(02)00047-X","article-title":"Molecular aspects of resistance to antitumor platinum drugs","volume":"5","author":"Brabec","year":"2002","journal-title":"Drug Resist Updat"},{"key":"key20180107182703_b7-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0065-230X(09)05005-2","article-title":"Clusterin and chemoresistance","volume":"105","author":"Djeu","year":"2009","journal-title":"Adv Cancer Res"},{"key":"key20180107182703_b8-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: mode of cytotoxic action and molecular basis of resistance","volume":"22","author":"Siddik","year":"2003","journal-title":"Oncogene"},{"key":"key20180107182703_b9-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/978-1-4615-3872-1_11","article-title":"Mechanisms of resistance to cisplatin","volume":"57","author":"Eastman","year":"1991","journal-title":"Cancer Treat Res"},{"key":"key20180107182703_b10-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0165-2478(00)00201-7","article-title":"CM1, a possible novel activation molecule on humanlymphocytes","volume":"74","author":"Hur","year":"2000","journal-title":"Immunol Lett"},{"key":"key20180107182703_b11-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S0198-8859(02)00405-6","article-title":"CM1 ligation initiates apoptosis in a caspase 8-dependent manner in Ramos cells and in a mitochondria-controlled manner in Raji cells","volume":"63","author":"Kim","year":"2002","journal-title":"Hum Immunol"},{"key":"key20180107182703_b12-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.humimm.2006.07.008","article-title":"Ligation of centrocyte\/centroblast marker 1 on Epstein-Barr virus-transformed B lymphocytes induces cell death in a reactive oxygen species-dependent manner","volume":"67","author":"Kim","year":"2006","journal-title":"Hum Immunol"},{"key":"key20180107182703_b13-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3892\/ijo.2012.1731","article-title":"Ligation of CM1 enhances apoptosis of lung cancer cells through different mechanisms in conformity with EGFR mutation","volume":"42","author":"Lee","year":"2013","journal-title":"Int J Oncol"},{"key":"key20180107182703_b14-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/onc.2011.384","article-title":"Molecular mechanisms of cisplatin resistance","volume":"31","author":"Galluzzi","year":"2012","journal-title":"Oncogene"},{"key":"key20180107182703_b15-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3802\/jgo.2010.21.4.262","article-title":"The effect of combined treatment with cisplatin and histone deacetylase inhibitors on HeLa cells","volume":"21","author":"Jin","year":"2010","journal-title":"J Gynecol Oncol"},{"key":"key20180107182703_b16-ijo-44-06-2016","first-page":"1131","article-title":"Synergism from sequenced combinations of curcumin and epigallocatechin-3-gallate with cisplatin in the killing of human ovarian cancer cells","volume":"31","author":"Yunos","year":"2011","journal-title":"Anticancer Res"},{"key":"key20180107182703_b17-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.canlet.2011.01.022","article-title":"Combination of Tetrandrine with cisplatin enhances cytotoxicity through growth suppression and apoptosis in ovarian cancer in vitro and in vivo","volume":"304","author":"Zhang","year":"2011","journal-title":"Cancer Lett"},{"key":"key20180107182703_b18-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ygyno.2012.04.007","article-title":"Molecularly targeted therapies in cervical cancer. A systematic review","volume":"126","author":"Zagouri","year":"2012","journal-title":"Gynecol Oncol"},{"key":"key20180107182703_b19-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1093\/annonc\/mdq723","article-title":"Epidermal growth factor receptor as a biomarker for cervical cancer","volume":"22","author":"Soonthornthum","year":"2011","journal-title":"Ann Oncol"},{"key":"key20180107182703_b20-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00280-007-0554-0","article-title":"Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells","volume":"61","author":"Chen","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180107182703_b21-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1349-7006.1999.tb00784.x","article-title":"N-acetylcysteine modifies cis-dichlorodiammineplatinum-induced effects in bladder cancer cells","volume":"90","author":"Miyajima","year":"1999","journal-title":"Jpn J Cancer Res"},{"key":"key20180107182703_b22-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/07357907.2010.535056","article-title":"Peroxiredoxin 6 overexpression attenuates cisplatin-induced apoptosis in human ovarian cancer cells","volume":"29","author":"Pak","year":"2011","journal-title":"Cancer Invest"},{"key":"key20180107182703_b23-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/ijc.20522","article-title":"Long-term activation of SAPK\/JNK, p38 kinase and fas-L expression by cisplatin is attenuated in human carcinoma cells that acquired drug resistance","volume":"112","author":"Brozovic","year":"2004","journal-title":"Int J Cancer"},{"key":"key20180107182703_b24-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ygyno.2007.05.030","article-title":"The combination of chemotherapy and intraperitoneal MegaFas Ligand improves treatment of ovarian carcinoma","volume":"107","author":"Etter","year":"2007","journal-title":"Gynecol Oncol"},{"key":"key20180107182703_b25-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2005.01.036","article-title":"Sensitivity to Fas-mediated apoptosis in high-risk HPV-positive human cervical cancer cells: relationship with Fas, caspase-8, and Bid","volume":"97","author":"Hougardy","year":"2005","journal-title":"Gynecol Oncol"},{"key":"key20180107182703_b26-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"97","DOI":"10.2165\/00063030-200216020-00003","article-title":"Novel strategies for overcoming multidrug resistance in cancer","volume":"16","author":"Baguley","year":"2002","journal-title":"BioDrugs"},{"key":"key20180107182703_b27-ijo-44-06-2016","first-page":"1229","article-title":"Defects in apoptotic signal transduction in cisplatin-resistant non-small cell lung cancer cells","volume":"13","author":"Ikuta","year":"2005","journal-title":"Oncol Rep"},{"key":"key20180107182703_b28-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1756-9966-29-49","article-title":"Up-regulation of Fas reverses cisplatin resistance of human small cell lung cancer cells","volume":"29","author":"Wu","year":"2010","journal-title":"J Exp Clin Cancer Res"},{"key":"key20180107182703_b29-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/01926230701320337","article-title":"Apoptosis: a review of programmed cell death","volume":"35","author":"Elmore","year":"2007","journal-title":"Toxicol Pathol"},{"key":"key20180107182703_b30-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"11933","DOI":"10.1158\/0008-5472.CAN-07-5185","article-title":"ERK-dependent MKP-1-mediated cisplatin resistance in human ovarian cancer cells","volume":"67","author":"Wang","year":"2007","journal-title":"Cancer Res"},{"key":"key20180107182703_b31-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.bcp.2011.08.018","article-title":"Silencing of the SNARE protein NAPA sensitizes cancer cells to cisplatin by inducing ERK1\/2 signaling, synoviolin ubiquitination and p53 accumulation","volume":"82","author":"Wu","year":"2011","journal-title":"Biochem Pharmacol"},{"key":"key20180107182703_b32-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.biocel.2010.05.007","article-title":"Piceatannol induces Fas and FasL up-regulation in human leukemia U937 cells via Ca2+\/p38alpha MAPK-mediated activation of c-Jun and ATF-2 pathways","volume":"42","author":"Liu","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"key20180107182703_b33-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1007\/s10620-009-1121-9","article-title":"The role of MAPK-ERK pathway in 67-kDa laminin receptor-induced FasL expression in human cholangiocarcinoma cells","volume":"55","author":"Duan","year":"2010","journal-title":"Dig Dis Sci"},{"key":"key20180107182703_b34-ijo-44-06-2016","doi-asserted-by":"crossref","first-page":"5455","DOI":"10.1182\/blood-2006-12-063958","article-title":"Atiprimod inhibits the growth of mantle cell lymphoma in vitro and in vivo and induces apoptosis via activating the mitochondrial pathways","volume":"109","author":"Wang","year":"2007","journal-title":"Blood"},{"key":"key20180107182703_b35-ijo-44-06-2016","first-page":"5940","article-title":"Reactive oxygen species-dependent c-Jun NH2-terminal kinase\/c-Jun signaling cascade mediates neuroblastoma cell death induced by diallyl disulfide","volume":"63","author":"Filomeni","year":"2003","journal-title":"Cancer Res"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2014.2361\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T18:30:52Z","timestamp":1515349852000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2014.2361"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,27]]},"references-count":35,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2014,3,27]]},"published-print":{"date-parts":[[2014,6]]}},"alternative-id":["10.3892\/ijo.2014.2361"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2014.2361","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,27]]}}}